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Characterization of globulin 
storage proteins of a low prolamin 
cereal species in relation to celiac 
disease
Gyöngyvér Gell1, Krisztina Kovács1, Gábor Veres2, Ilma R. Korponay-Szabó3 & Angéla Juhász1,†
Brachypodium distachyon, a small annual grass with seed storage globulins as primary protein reserves 
was used in our study to analyse the toxic nature of non-prolamin seed storage proteins related to 
celiac disease. The main storage proteins of B. distachyon are the 7S globulin type proteins and the 
11S, 12S seed storage globulins similar to oat and rice. Immunoblot analyses using serum samples from 
celiac disease patients were carried out followed by the identification of immune-responsive proteins 
using mass spectrometry. Serum samples from celiac patients on a gluten-free diet, from patients 
with Crohn’s disease and healthy subjects, were used as controls. The identified proteins with intense 
serum-IgA reactivity belong to the 7S and 11–12S seed globulin family. Structure prediction and epitope 
predictions analyses confirmed the presence of celiac disease-related linear B cell epitope homologs 
and the presence of peptide regions with strong HLA-DQ8 and DQ2 binding capabilities. These results 
highlight that both MHC-II presentation and B cell response may be developed not only to prolamins 
but also to seed storage globulins. This is the first study of the non-prolamin type seed storage proteins 
of Brachypodium from the aspect of the celiac disease.
Immune reactive peptides of prolamin type storage proteins of cereal species such as wheat, rye and barley are 
considered as trigger molecules in the development of celiac disease (CD), a systemic autoimmune disease caus-
ing villous atrophy in the small intestine. Celiac disease has a strong genetic component and occurs only in sub-
jects carrying the human leukocyte antigen (HLA) DQ2.5, DQ8 or DQ2.2 haplotypes which act as cell surface 
receptors for the toxic peptides on antigen presenting cell. Deamidation of wheat gliadin peptides by gastric acid 
or by certain enzymes (e.g. the main celiac autoantigen, type-2 transglutaminase), strongly increases their immu-
nogenic properties by making them properly fitting into the binding groove of DQ2 and DQ8. Antibodies against 
these deamidated gliadin peptide (DGP) antibodies have higher diagnostic value than conventional anti-gliadin 
(AGA) antibodies1,2. Today the only effective treatment is a lifelong gluten-free diet that is often rich in rice, corn, 
quinoa, teff or amaranth. The common characteristic of these whole grain sources is that their seed is rich in stor-
age globulins instead of prolamin like storage proteins.
Brachypodium distachyon is a diploid annual wild grass that belongs to the Pooideae subfamily of the grasses, 
and based on the recent phylogenetic analyses is the closest wild relative of wheat and barley3,4. However, its 
storage protein composition and the extraction behaviour of these proteins make B. distachyon closer to rice 
or oat than to wheat endosperm proteins5. B. distachyon accession Bd21 offers many advantages, such as 
self-fertility, simple nutrient requirements and short lifecycle. Sequencing and annotation of the Bd21 genome 
were recently completed, making further functional proteomic studies feasible6–8. Along with previous results 
of Laudencia-Chingcuanco and Vensel9, the study by Larré and co-workers5 has revealed that the main storage 
proteins of B. distachyon are the 11S, 12S and 7S globulin type proteins similar to oat and rice. The prolamins, 
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including the avenin-like proteins and the gliadin-like prolamins, represent less than 12% from the total pro-
tein content that is significantly lower compared to wheat. 11S–12S globulins account for 70–80% of total seed 
protein content5. Due to its low prolamin content, B. distachyon may serve as an excellent source to investigate 
the immune-reactive capacity of non-prolamin seed proteins. In our previous study, the published chromosome 
specific B. distachyon genome sequences and a seed specific cDNA library data were used for sequence-based 
identification of proteins with regions identical to known celiac disease-specific epitopes10. Next to proteins with 
nutrient reservoir activity proteins with nucleic acid or protein binding activities, transcription regulator function 
and catalytic functions were identified. Although the percentage of epitope containing proteins with nutrient 
reservoir activity was low (6.8%), this value has increased when epitope homologues over 80% identity were also 
considered. These results have highlighted the presence of possible cross-reactive epitope homologues to celiac 
disease related trigger molecules. Although Brachypodium is not considered for human nutrition, we took advan-
tage of its use as a model species for the understanding whether abundant non-prolamin cereal seed proteins with 
linear epitope homologues play a role in the development of humoral immune response and to help select other 
food sources suitable for gluten free diet. In our study high-resolution proteomic analysis of total protein extracts 
of mature Brachypodium seeds and serum samples of patients suffering in celiac disease were used to characterize 
seed proteins with elevated immune reactivity.
Materials and Methods
Patients and Sera. Serum samples from celiac patients with known HLA-DQ haplotypes and positive for 
celiac disease antibodies on gluten intake (n = 13, 8 females, 5 males), median age 5.7 years, range 1.4–13.5 years).
Serum samples from celiac patients adhering to a strict gluten-free diet (GFD) resulting in normalised antibodies 
(anti-transglutaminase IgA < 10 U/l) and mucosal healing (n = 3), from ten newly diagnosed Crohn’s disease 
patients with ileocolon manifestation (median age 6.4) and eight healthy control subjects were used for immu-
noblotting studies. Celiac disease was diagnosed according to the criteria of ESPGHAN (European Society of 
Paediatric Gastroenterology, Hepatology and Nutrition) and according to Marsh criteria and all patients had 
Marsh III grade intestinal lesions and elevated IgA anti-transglutaminase (TG2) IgA and IgG antibody serum 
levels (> 200 U/l)11,12. Six celiac patients were HLA DQ2.5 homozygous; five were DQ8 homozygous, and one 
was heterozygous (DQ8/X). The exact DQ typing result was not available in one other case. One of the DQ8 
cases developed type-1 diabetes mellitus two years after celiac disease diagnosis. Informed written consent to the 
collection of serum samples was given by the parents. All the methods of subject recruitment, data collection, 
and experiments were performed in accordance with relevant guidelines and regulations. All experiments were 
approved by the ethics committee of the Heim Pál Children’s Hospital, Budapest and the Semmelweis University 
Regional and Institutional Committee and Research Ethics. Serum samples were collected during the diagnostic 
procedure of celiac disease for the clinical investigation of celiac antibodies according to ESPGHAN guidelines 
and used later for the experiments with the permission of the Ethical Committee of the Heim Pal Children’s 
Hospital, Budapest.
Protein Extractions. Total protein of 50 mg-s of crushed B. distachyon inbred line Bd21 seeds were extracted 
following the protocol of Dupont and co-workers13. Briefly, an SDS-Tris extraction buffer (pH 6.8) containing 
2% SDS, 10% glycerol, 50 mM DTT and 40 mM Tris-HCl, pH 6.8 was used to extract the total protein at room 
temperature for one hour with a regular gentle vortexing. The extract was centrifuged at 16000 g for 15 minutes. 
The supernatant was precipitated with four volume ice-cold acetone. Five biological replicates were used in the 
extraction process.
2D Gel Electrophoresis and Immunoblotting. Following the precipitation the pellet was solubilized 
with IEF buffer (8 M urea, 2% CHAPS, 100 mM DTT, 0.2% CA and 0.1% Bromophenol Blue). The isoelectric 
focusing was carried out in 7 cm Immobiline DryStrips pH 3–10 (GE Healthcare), under overnight rehydrating 
conditions with 200 μ g protein in 150 μ l IEF buffer. 12% polyacrylamide gels were used to separate proteins based 
on their molecular weight. 2D GE was made in three technical replicates. Because all of the 2D protein patterns 
from the different biological and technical replicates were identical, the final on-line nano-LC-MS/MS was made 
from three technical replicates 2D GE, and the spots were bulked.
After the 2D GE proteins were transferred to ImmobilonP PVDF membrane (Millipore, Billerica, USA) and 
blocked for 1 hour with 5% BSA and 0.05% TWEEN20 followed by an overnight incubation at 4 °C with 1:20 
diluted blood sera. The immune-reactive proteins were detected with anti-Human IgA peroxidase- conjugated 
antibody produced in goat (Sigma-Aldrich-A0295) in the presence of 4-Chloro-1-Naphthol chromogenic perox-
idase substrate. Immune responsive protein spots were excised and sent for protein identification using on-line 
nano-LC-MS/MS. Rice glutelin antibody coupled with anti-rabbit IgA as a secondary antibody was used in 2D 
Western blot analysis to confirm the presence of seed storage globulins14.
Protein Identification by on-line nano-LC-MS/MS. Gel spots were in-gel digested for 4 hrs at 37 °C 
with sequencing grade modified Trypsin (Promega, V5111) after reduction with DTT (Sigma-Aldrich) and alky-
lation with Iodoacetamide (Sigma-Aldrich). The peptide extracts were analysed by mass spectrometry, using 
on-line nano-LC-MSMS technique on a Waters nano-Acquity UPLC coupled with Thermo LTQ-Orbitrap-Elite 
mass spectrometer. Ion-trap CID spectra were acquired from the ten most intense peaks after each sur-
vey scan. Proteome Discoverer (Thermo) was used for generating MSMS peak lists and in-house Protein 
Prospector, v:5.10.17 was used for database search against the Brachypodium distachyon sequences from the 
UniProtKB.2014.3.12.random.concat (30183/53249714 entries searched) database. The following search param-
eters were used for tryptic peptides: carbamidomethyl Cys as constant, oxidation of Met, pyro-Glu from Gln 
and protein N-terminal acetylation as variable modifications. Only fully specific peptides were considered with 
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the maximum of 1 missed cleavage site. Mass tolerance was set to 5 ppm for the survey and 0.6 Da for the MSMS 
measurements. Minimum protein and peptide score was 51 and 20 respectively as acceptance criteria. False dis-
covery rate was calculated for each 2D gel spot identification and found to be less than 1% in all cases. (FDR: 
2*number of decoy peptide match/number of identified spectra.) In the case of homologous proteins, the one 
with the highest protein score and the bigger sequence coverage was listed. Three dominant proteins from each 
spot were selected for further in-silico analyses.
Sequence Analyses and Epitope Predictions. Protein sequences identified based on the on-line 
nanoLC-MS/MS analysis were retrieved from the UniProt database and were used for detailed epitope map-
ping analyses and protein characterizations. p-BLAST was used to find protein homologues in Poaceae. Celiac 
disease-specific linear T-cell and B-cell epitopes were collected from the ProPepper database15. Epitope mapping 
was carried out using motif search algorithm of the CLC Genomic Workbench (8.5.1). A threshold of minimum 
70% sequence identity was used to identify wheat epitope homologs in Brachypodium protein hits. A minimum 
epitope length of 4 amino acids was used for 100% hits, while for peptide homologs with imperfect epitope 
matching six consecutive amino acids were used as the limit. MHC-II peptide binding prediction algorithm of 
the IEDB immune epitope database and analysis resource was used to predict protein regions with possible T-cell 
specific linear epitopes. MHC-II alleles, DQA1*05:01/DQB1*02:01 (DQ2.5) and DQA1*03:01/DQB1*03:02 
(DQ8) were used to the predictions. The predictions were made on 1/7/2016 using the IEDB analysis resource 
Consensus approach16,17. Using a 14aa sliding window, 15aa long peptides were produced from the analysed pro-
tein sequences. Binding affinity values of these peptides library were compared against a learning set of peptides 
similar in size randomly selected from the Swiss-Prot database and were used as percentile rank18. Peptides with 
small percentile ranks represented good binders. A cut-off value of top 1% was used to select potential pep-
tides with the strongest binding abilities. Predicted T-cell binding epitopes were mapped to the selected protein 
sequences and also utilised in the structure analyses. Intrinsically disordered regions and binding ability of the 
immune reactive protein hits was analysed by the ANCHOR analysis web server19. Positions of epitope hits high-
lighted and their relative positions evaluated. Surface accessibility was determined using the Emini algorithm and 
Kolaskar-Tongaonkar antigenicity scale. Protein structure prediction was carried out using the I-TASSER protein 
structure and function prediction suite20. Identified B-cell and predicted T cell epitopes were highlighted on the 
structure using CLC Genomics Workbench (8.5.1).
Results
Brachypodium distachyon, a model plant of monocot species with low prolamin content was investigated to 
characterise immune reactivity against non-prolamin proteins in the seed. Altogether 152 proteins spots were 
detected with Coomassie Brilliant Blue (CBB) staining from which 28 immune-reactive proteins spots were ana-
lysed by on-line nanoLC-MS/MS. Antibody reactivity against Brachypodium proteins was detected in all the 
celiac disease patients and two of Crohn’s disease patients, but in the latter only against two protein spots (spot 
27 and 28) (Fig. 1). For detailed results see the Supplementary Table S1. While positive IgA reactions of celiac 
serum samples were detected against proteins from a wide range of molecular weight (approximately 15 kDa to 
65 kDa) and variable isoelectric points, the protein spots showing immune reactivity with Crohn’s disease serum 
samples possessed an approximate molecular weight of 24 kDa. In pilot experiment for IgG reactivity and using 
three of the celiac serum samples, we only found a non-specific reaction with Brachypodium protein spots 27 and 
28 (results not shown). No proteins reacted when sera of healthy controls and sera of patients on strict gluten free 
diet were applied. Overall experimental layout is shown in the Supplementary Fig. S1.
Predominant immune-reactive proteins are presented in Table 1 along with their protein family classification, 
identified homologs and number of reactive spots. Additional protein hits with their protein score, the num-
ber of unique peptides and the sequence coverage are presented in Supplementary Table S2. Most of the spots 
were identified as 7S or 11–12S type seed storage globulins. Variants of 7S-type storage globulins (also called 
Glb-1 in cereals), were mostly identified from spots within the molecular weight range of 35 to 65 kDa (spot ID 
1–6, 8–15, 17–18). 11–12S storage globulins (spot ID 7, 22–28) were identified in the region of below 30 kDa. A 
few prolamin-type storage protein sequence hits were also identified as secondary or tertiary protein hits with 
similar sequence coverage values: gamma gliadin-like proteins (spot ID 1, 2, 3), HMW glutenin-like proteins 
– (spot ID 17–18) and LMW type glutenins (spot ID 28–29), respectively. Some enzymes and proteins with 
non-storage function were identified in the 35 kDa region, like glucose/ribitol dehydrogenase (spot ID 16, 18, 19, 
20), aldo-keto reductase (spot ID 20), xyloglucan endo-transglucosylase/hydrolase (ID 21) and aspartic peptidase 
(spot ID 14) (Table 1, Supplementary Table S2). Our findings show that multiple protein spots were identified as 
the same protein with slightly different mass or pI values. These results are confirmed by other studies showing 
that post-translational modification events, such as phosphorylation and glycosylation are common phenomena 
in the mature B. distachyon seed proteome. The 7S, 11S-and 12S type globulins had occurred from 22 kDa to 
64 kDa with different pI values5,21 (for details see the Supplementary Info. S1).
Two 7S globulins (Uniprot ID I1GPS5 and I1GMC8) were predominantly identified from the spots. I1GPS5 
was recognised as a primary hit from 14 protein spots. This protein showed the highest similarity to the 
Globulin-3 and Globulin-3A wheat storage protein homologs (Uniprot ID B7U6L4 and I6QQ39). I1GMC8 was 
identified in two protein spots and showed the highest sequence similarity to a Globulin 1S type protein identified 
from Triticum urartu (M7ZQM3). I1HNH9 Brachypodium protein showed the highest homology to a 11S globu-
lin (A. sativa Q38780). I1HMK7 and I1IPF2 proteins were identified as 12S globulins, with strongest similarities 
to 12S seed storage proteins in A. sativa (P12615 and P14812). Sera most frequently reacted to the Globulin-3A 
wheat storage protein homolog (69.23% - I1GPS5) and the 11S and 12S type globulins (76.92% - I1HNH9 and 
I1HMK7). A low-molecular-weight glutenin-like homolog (69.23% I1HMR6) was also highly immune reactive 
to the celiac disease patients’ sera.
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Figure 1. Identification of celiac disease-related proteins of Brachyprodium distachyon ‘Bd21′ using anti-
IgA detection and patients’ blood sera. (A) - 2D gel electrophoresis of total protein extract of inbred line Bd21. 
Proteins were separated on 3–10 pH IPG strips followed by separation on 12% acrylamide gels. Labelled protein 
spots represent immune-reactive proteins and were sent for on-line nanoLC-MS/MS analyses. Molecular weight 
range is marked on the left-hand side. (B to F) - representative immunoblots using sera with IgA reactivity 
of therapy naïve celiac disease patients (B – HLA DQ2, C – HLA DQ8, D – HLA DQ8/X), ileocolic affected 
therapy naïve Crohn’s disease patient (E), HLA DQ2 celiac disease patient on gluten free diet and a healthy 
control (G). H –Western blot analysis of total protein extract was performed using rice glutelin antibodies12 and 
anti-rabbit IgA (Sigma-Aldrich) as secondary antibody.
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To prove the presence of seed storage globulins within the immune reactive protein spots, Western-blot anal-
ysis was carried out using primary antibodies specific for rice glutelins, the rice homologs of 11S seed storage 
globulins (Fig. 1H). Strong globulin signals were detected from the protein spots ID 1 to 14 and 22 to 28.
The most significant globulin hits (I1GPS5, I1GMC8, I1HMK7, I1IPF2 I1HNH9) as well as the most fre-
quently identified prolamin protein (I1HRM6) were subjected to in-silico sequence analyses structure prediction. 
Two adjacent cupin-1 domains characteristic both on 7S and 11S–12S seed storage globulins were found in all of 
the Brachypodium globulin hits (Fig. 2). Regions with possible binding capabilities to structured protein partners22  
were found in most of the analysed globulin proteins. Strong binding regions were located at the border of 
ordered-disordered regions in the 7S-type globulins (I1GPS5 and I1GMC8), while significantly weaker binding 
regions were found in the 11S and 12S globulins, and no binding region was found in the analysed Brachypodium 
prolamin sequence. (Fig. 2)
Ten amino acid long peptides with over 70% sequence homology to B-cell specific linear gluten epitopes 
were identified in close proximity to the binding regions of the I1GPS5 protein (Table 2). The identified epitope 
homologs represented peptides with polyQ stretches and were positioned in two glutamine-rich regions of the 
protein. Additionally, a six residues long peptide (QPEQPF) was identified in the 11S seed storage globulin, 
I1HNH9. This peptide was the deamidated version of a known immune reactive AGA specific B cell epitope 
QPQQPF (IEDB Epitope ID 147232) that gets deamidated during celiac disease process. This deamidated ver-
sion represents one of the primary targets of serum DGP antibodies in celiac disease. Interestingly, none of 
the I1HNH9 Poaceae homologs contained this deamidated peptide. No epitope homologs were found in the 
metabolism-related proteins.
When gluten related known T-cell epitopes were mapped to the Brachypodium proteins, no known epitopes 
were found. However, a type-I diabetes-specific T-cell epitope, EEQLRELRRQ23 was identified from I1GPS5 with 
100% sequence identity at the position 281. To check for novel T cell epitopes, MHC-II binding predictions were 
carried out from the main 7S, and 11S–12S globulin hits using HLA-DR3-DQ2 and HLA-DR4-DQ8 MHC-II 
haplotypes (Fig. 3 and Supplementary Fig. S2). DRB1*0301, DRB1*0405 DRB1*0401 and DRB1*0402 HLA alleles 
were used as primary type-I diabetes-related MHC-II alleles (Supplementary Fig. S2). In the analysed 7S globulin 
protein (I1GPS5) predicted DQ2 and one of the predicted DQ8 epitopes were located between the two cupin-1 
domains (the I1GPS5 section between residues 254 to 314). This region also harboured the published T1D epitope 
in the 281–290 aa region (Supplementary Fig. S2). Some of these potential epitope regions and the core region 
of the DQ2 and DQ8 epitopes were positioned at the surface of the protein molecule. There were epitopes also 
overlapping with peptides remaining intact after in-silico digestion of the protein sequences using gastrointestinal 
enzymes, such as pepsin, trypsin or chymotrypsin, respectively (Supplementary Fig. S3). Further DQ8, DR3 and 
DR4 specific peptide candidates were found in the first cupin-1 domain. Contrary, no epitope-dense region was 
predicted between the two cupin-1 domains in the 11S and 12S seed storage globulins (I1HNH9, I1HMK7 and 
I1IPF2) (Fig. 3 and Supplementary Fig. S2).
Tertiary structure model of the I1GPS5 7S globulin monomer was built using publicly available crystal struc-
tures of 7S globulins isolated from plants. The identified gluten specific B cell epitope homologs that are in about 
350 amino acid distance from each other in the sequence were mapped in close structural proximity. One of the B 
cell epitope homologs is located on the outer surface of the beta-barrel formed by the second cupin-1 domain. The 
predicted HLA-DQ specific T-cell epitopes and the identified type-I diabetes epitope were located at the opposite 
site of the protein molecule also potentially exposed to digestive enzymes (Fig. 4A,B,C). In the case of the 11S seed 
storage globulin I1HNH9 the predicted DQ2 epitope was in a buried position while the B cell epitope homolog 
QPEQPF located on the surface of the protein (Fig. 4D and E).
Brachypodium hit 
(Uniprot ID) identified 
by on-line nanoLC-
MS/MS
Protein family 
type Best Poaceae homolog
Number 
of reactive 
protein spots 
on 2D GE
Number of celiac 
disease sera with 
IgA reactivity 
(n = 13)
Number of Crohn’s 
disease sera with 
IgA reactivity 
(n = 10)
Number of GFD 
celiac sera with 
IgA reactivity 
(n = 3)
Number of 
healthy controls 
with IgA 
reactivity (n = 8)
I1GPS5 7S globulin Globulin 3 (B7U6L4, T. aestivum) 14 9 0 0 0
I1GMC8 7S globulin Globulin 1S (M7ZQM3, T. urartu) 2 8 0 0 0
I1HNH9 11–12S globulin 11S globulin (Q38780, A sativa) 2 10 2 0 0
I1HMK7 11–12S globulin 12S seed storage globulin (P12615, A sativa) 4 10 2 0 0
I1IPF2 11–12S globulin 12S seed storage globulin (P14812, A sativa) 1 8 0 0 0
I1HMR6 Prolamin–like LMW-GS (H6VLQ5, T. aestivum) 1 9 0 0 0
I1HIH2 Metabolism related proteins Aldose reductase (M7Z0 ×  1, T urartu) 1 8 0 0 0
I1HM37 Metabolism related proteins
Glucose and ribitol dehydrogenase-like 
protein (M8C904, Ae tauschii) 1 5 0 0 0
I1H5 × 3 Metabolism related proteins
Uncharacterized protein (M8BEB8, Ae. 
tauschii) 1 5 0 0 0
I1GNN1 Metabolism related proteins
Xyloglucan endotransglucosylase/hydrolase 
(Q56TP4, T aestivum) 1 4 0 0 0
Table 1.  Identified Brachypodium distachyon protein hits, and their immune reactivity against serum IgA 
antibodies originating from celiac disease patients, Crohn’s disease patients, healthy controls and celiac 
patients on gluten free diet. Numbers of immune reactive sera represent patients reacting on protein spots 
within a particular protein type.
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Figure 2. Secondary structure analyses of the identified celiac disease-related proteins. Disordered regions 
and disordered binding regions were predicted using ANCHOR. Red curves (IUPred) represent intrinsically 
disordered regions, blue curves (ANCHOR) predicts binding regions using primary sequence information. 
Binding regions are labelled on the sequence with dark blue. Mapped B cell epitope homologs (labelled with 
cyan blocks) and the identified type-I diabetes-related T-cell epitope (labelled with orange block) are presented 
along with the identified cupin-1 and gliadin protein domains (labelled with grey blocks). (A) Disordered 
regions were identified in 7S globulin-type proteins (I1GPS5 and I1GMC8) at the N-terminal domain and in 
the second cupin-1 domain. Strong binding regions were preceding both cupin-1 domains, and some binding 
regions were located in the second cupin-1 domain. Mapped gluten protein specific linear B-cell epitope 
homologs were found in proximity to some of the disordered binding regions. Type-1 diabetes-related T-cell 
epitope was characteristic on I1GPS5 protein and was located between the two cupin-1 domains. (B) Disorder 
was less characteristic on 11S–12S globulins (I1HNH9, I1HMK7 and I1IPF2). Two weaker binding regions 
were predicted between the cupin-1 domains. B cell epitope homologs were mapped in the same region. I1IPF2 
protein did not contain any binding regions. (C) The identified prolamin-like protein (I1HRM6) contained a 
longer disordered section before the gliadin domain. Two B cell epitope homologs were mapped to the gliadin 
domain.
Protein Homologue region and position Celiac disease-specific B-cell Epitope Sequence Matched epitope IEDB ID
Sequence 
homology
I1GPS5 DEKQQQQQQQESR89–101,
LQQQQQQQQQ, QQQQQQQQQI QKQQLQQQQQ 
QQQQQQQQLQ QQQQQQQPLS QQQQQQQILQ
148680 148881 148771 
148880 149441 148877 70%
I1GPS5 QGRGQQQQQQQGRY436–449
LQQQQQQQQQ, QQQQQQQQQI QQQQQQQQLQ 
QQQQQQQPLS QQQQQQQILQ QPISQQQQQQ
148680 148881 148880 
149441 148877 149432 70%
I1GMC8 — — — —
I1HNH9 QPEQPF271–276 QPQQPF 147232 83%
I1HMK7 QKQPFLPIEP252–261 QPQPFLPQQP 149434 70%
I1IPF2 — — — —
I1HMR6 CQQLALIPVQSR110–121 CQQLWQIPEQ QLWQIPEQSR 149280 149429 70% 70%
I1HMR6 FKQQLGQGQQ133–142 QKQQLQQQQQ 148771 70%
I1HIH2 — — — —
I1HM37 — — — —
I1H5 × 3 — — — —
I1GNN1 — — — —
Table 2.  Gluten specific B cell epitope homologs of the identified Brachypodium distachyon proteins. The 
sequence of homologue region and position in the protein. The mapped epitopes and their IEDB epitope IDs 
are highlighted. Sequence homology based on which the peptide was accepted as an epitope homologue is 
described in the materials and methods. The QPEQPF sequence is identical to the processed (deamidated) form 
of the corresponding wheat epitope.
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Discussion
Based on our previous studies a high number cereal grain proteins may contain peptides rich in proline and 
glutamine making them a target for celiac disease-related antigen presenting cells and immunoglobulins10,15,24. 
In wheat, the majority of these proteins belong to the prolamin superfamily and are a natural compound of the 
wheat gluten. However, there are some non-prolamin type proteins that also contain peptides identical or strongly 
similar to gluten-specific T-cell and B-cell epitopes10,15.
Some previous studies have focused on the investigation of immune reactivity and toxic behaviour of 
non-gluten proteins of wheat related to celiac disease25–28. Recently, Huebener and colleagues have analysed 
the possible involvement of non-gluten proteins as target antigens in celiac disease related humoral response29. 
Serine-protease inhibitors, alpha-amylase inhibitors, farinins and seed globulins have demonstrated a significant 
immune response. Farinins, alpha-amylase inhibitors and serine–protease inhibitors are proteins with a con-
served cysteine skeleton highly similar to that of prolamins and without the presence of long Q and P rich repet-
itive regions30. Additionally, 35% of celiac disease patient’s sera showed reactivity against protein spots identified 
Figure 3. MHC II class T cell epitope prediction of Brachypodium 7S and 11S–12S globulin proteins using 
HLA DQ2 and DQ8alleles and IEDB analysis resource Consensus tool. Selection of predicted binders was 
carried out using top 1% binders based on consensus percentile rank values. Predictions were calculated for 
each allele separately. Predicted epitopes are mapped to the protein sequences.
Figure 4. In-silico structure prediction of the Brachypodium 7S globulin (I1GPS5) and 11S globulin 
(I1HNH9) proteins. Monomer globulin structures were modelled using publicly available plant orthologues 
as structural templates and the I-Tasser protein structure and function prediction server. Positions of identified 
gluten specific B cell epitope homologs and the predicted HLA DQ2 and DQ8 specific T cell epitopes were 
mapped to the structure. (A–C) I1GPS5; (D,E) I1HNH9.
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as seed globulins using the protein extract of ‘Butte86′ wheat28. Increased celiac serum antibody reaction was also 
measured against cereal globulin extracts by Troncone et al27. Seed storage globulins, like Glo-3A from wheat, 
were related to celiac disease and type-I diabetes in a high-risk type-I diabetes population31–33. Celiac disease 
cases having first-degree type-I diabetes relatives showed a higher response to Glo-3A protein at the early stage 
of illness even prior transglutaminase-2 autoantibodies were detected32. They suggested that Glo-3 wheat glob-
ulins are either antigenic and participate in the development of these diseases or the high immune reactivity 
against these proteins indicates an abnormal gut barrier function, lack of oral tolerance or cross-reactivity with 
self-antigens. Epitope patterns of I1GPS5 and wheat Glo-3A (B7U6L4) along with some other orthologues found 
in wheat and related cereal species highlighted epitope dense conserved binding regions between the two cupin-1 
domains along with some other conserved positions in both cupin-1 domains (Supplementary Fig. S4).
We also investigated whether increased unspecific peptide recognition due to the increased gut permeability 
in Crohn’s disease patients would cause antibody reactivity. The lack of immune response with Crohn’s disease 
sera and sera from celiac patients on a strict gluten-free diet strengthen the observations that these reactions were 
specific for the active celiac disease. Our results thus indicate that in celiac disease, not only prolamins but also 
non-prolamin storage proteins, like the Triticum homologues of 7S and 11S–12S globulins can trigger B cell acti-
vation and humoral response with potentially adverse effect on the villi. Sequence homologs with polyQ chains or 
natural deamidated variants of immune reactive peptides like the B cell peptide in the 11S seed storage globulin 
I1HNH9 can also serve as antigens. The sequence of a known highly immunogenic epitope QPQQPF is present 
in a natural deamidated version (QPEQPF) in one of the 11S seed storage globulins. The PQQ to PEQ modifi-
cation has a proven positive effect on the strength of antibody binding34. Although 7S and 11S–12S seed storage 
globulins both represent strongly conserved protein families with cupin-1 domains in cereals our epitope analyses 
highlighted some remarkable differences between the protein families (Supplementary Fig. S2). These differences 
indicate the presence of possible sub-classes with various immune reactive potential. The amount of these unique 
globulin sub-classes can also be different in the grains of the different species, with a significantly lower amount 
expressed in wheat and in cereals, where prolamins serve as major storage protein components. This fact partially 
explains why these proteins were overlooked compared to the most abundant prolamins in wheat, rye or barley. 
Grains of cereals as oat, rice or Brachypodium distachyon are enriched in seed storage globulins.
Our study confirmed that globulin-type cereal seed storage proteins are specifically related to celiac disease, 
as patients suffering in other immunological, inflammatory diseases, like Crohn’s disease did not recognise these 
globulin-type cereal storage proteins. Adverse results of the immunoblot analyses with sera of celiac patients 
on a gluten-free diet had also strengthened the assumption that seed storage globulins may act as secondary B 
cell stimulants due their strong sequence homology to epitopes originated from the primary gluten triggers. In 
progressive stages of the disease the villous atrophy and the increased gut permeability contributes why these 
proteins can serve as cross antigens. The recovered intestinal mucosa of the celiac patient on a strict gluten-free 
diet prevents better the passage of ingested proteins and probably, in this way can be the strong immune reactivity 
controlled.
On the other hand, prediction novel HLA class II restricted T cell epitopes with binding ability to HLA DQ2 
and DQ8 molecules raise the possibility that these protein families may also be involved in the development of 
the disease. The conserved presence of predicted HLA DQ2 and DQ8 binding regions that also overlap with 
known and predicted type-1 diabetes-related epitope regions implicate that these proteins can also serve as trig-
ger molecules in these diseases. Type-I diabetes and celiac disease share a similar genetic background, as both 
conditions are associated with the presence of HLA DQ2 and HLA DQ8 haplotypes. This common genetic back-
ground can partially explain the relatively high prevalence of patients with both diseases. In patients diagnosed 
with both diseases, type-I diabetes develops first, suggesting that strict gluten-free diet may decrease the risk of 
diabetes if implemented in the prediabetic period35. Interestingly, none of the patients involved in our study was 
diagnosed with type-I diabetes at the stage when celiac disease was diagnosed. However, one patient with an 
MHC II haplotype HLA DQ8 neglecting the gluten free diet was also diagnosed with type-I diabetes several years 
later. Studies have revealed about ten times higher risk of development of celiac disease in children with type I 
diabetes36. Studies focusing on a population-based screening of celiac disease with subsequent type-I diabetes37,38 
have revealed an increase in type 1 diabetes before the age of 20 years in individuals with prior celiac disease. The 
age distribution of celiac patients involved in our study varied from 1.4 years to 13.5 years, all of them under 20 
years. Although the prevalence of type-I diabetes developed later is not known for these patients, except for one 
case, when gluten free diet was neglected, based on previous findings, ratio of celiac patients with subsequent 
diagnoses of type-I diabetes is rather low. In the study of Ludvigsson et al.38 only ca. 1.04% of individuals with 
celiac disease were diagnosed with type-I diabetes in the later stage. Shared nutritional factors, such as presence 
of gluten-containing cereals in the daily diet and common HLA DQ2 and DQ8 haplotypes may explain this 
combined risk.
Conclusions
In summary, our results indicate that both in celiac disease and type-I diabetes MHC-II presentation and B cell 
response may be developed not only for prolamins but also for seed storage globulins even in distant relatives of wheat, 
such as Brachypodium distachyon, having seed storage globulins similar to oat and rice. Brachypodium distachyon 
accession Bd21 with a small diploid genome size (272 Mbp) offers many advantages, such as self-fertility, simple 
nutrient requirements and short lifecycle. Sequencing and annotation of the Bd21 genome were recently com-
pleted, making further functional proteomic studies feasible. All these features make the Brachypodium distach-
yon an excellent research material, even though it is at present not directly considered for human use. However, its 
seed storage proteins, especially globulins, belong to quite conserved proteins in plants, which when eaten, may 
cause some problems due to the presence of some B-cell epitope homologs and possible T-cell reactive peptides 
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present in the globulin fraction. Therefore, such cereals would not be harmless food alternatives for celiac patients 
despite negative results on conventional R5 ELISA for celiac-related toxicity (data not shown). High-resolution 
2D gel electrophoresis followed by immunoblotting and protein identification have proved that 7S and 11S–12S 
seed storage globulins may act as antigens for celiac disease specific IgA antibodies. Structure prediction analyses 
and epitope mapping results indicate that these proteins do not contain known gluten related T cell epitopes. 
However, additional epitopes predicted with strong binding capabilities to HLA DQ2 and HLA DQ8 are present 
between the two cupin-1 domains or at the surface of the beta-barrel formed by the domain of the cereal 7S and 
11S–12S globulins. Storage globulins are only present as contaminants in the wheat gluten; therefore they play a 
less significant role. Contrary to this, seed storage globulins are the main source of nutrient storage in cereals like 
rice, oat or Brachypodium5. Their presence in the endosperm of these cereal species is more remarkable compared 
to that in wheat or barley. Despite the strongly conserved structure of 7S globulins, proteins like Glo3A in wheat 
and I1GPS5 in Brachypodium and some of the 11S–12S globulins represent a special class of seed globulins with 
an epitope dense region between the two cupin-1 domains and therefore might represent a higher risk for celiac 
disease patients. Our study draws attention on the presence of conserved seed storage protein families in various 
cereal species, such as wheat, oat, rice and Brachypodium. Although 7S and 11S–12S seed globulins are present in 
low amount in the wheat grain, they represent major storage protein groups in species like oat or rice. Therefore 
the presence of some epitopes in highly conserved regions may be also characteristic on orthologues in other 
species. Mapped and predicted epitopes found in these proteins suggest that both in celiac disease and type-I 
diabetes MHC-II presentation and B cell response may be developed not only for prolamins but also for seed 
storage globulins. The level of the response to globulins may depend on the type of seed globulins and amount of 
proteins with immune responsive peptide content. It is also suggested to perform further investigations whether 
diets enriched in seed storage globulins (like rice or oat) inhibit the sufficient healing, especially in patients with 
combined high risk to type-I diabetes and proven susceptibility to these proteins.
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